2m 2m 2m 2m 2m 2m 2m
Konink Phil Sp ADR (PHG)
NYSE
$26.61-$0.37 (-1.39%)
Price as of Jun 23, 2026 4:10 PM EDT- $26.2BMarket Cap
- 28.07%1-Year Change
- Medical DevicesIndustry
Konink Phil Sp ADR (PHG)
$26.61-$0.37 (-1.39%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 17.8B -1.04% | 18.0B -0.81% | 18.2B +1.92% | 17.8B +3.91% | |
Cost of Revenue | 9.8B -4.61% | 10.2B -4.41% | 10.7B +0.83% | 10.6B +6.46% | |
Gross Profit | 8.1B +3.67% | 7.8B +4.36% | 7.4B +3.53% | 7.2B +0.36% | |
Sales and Marketing Expense | 4.3B -3.21% | 4.5B -0.84% | 4.5B -1.84% | 4.6B +8.24% | |
Research and Development Expense | -1.7B -2.69% | -1.7B -7.57% | -1.9B -189.87% | 2.1B +16.45% | |
Depreciation and Amortization Expense | 240.0M -38.78% | 392.0M +35.17% | 290.0M -20.11% | 363.0M -72.56% | |
Total Operating Expenses | 628.0M +7.90% | 582.0M -4.28% | 608.0M -9.39% | 671.0M +12.02% | |
Operating Profit | 1.4B +169.19% | 529.0M +560.00% | -115.0M -92.48% | -1.5B -376.49% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -288.0M 0.00% | -288.0M +3.97% | -277.0M +17.87% | -235.0M +47.80% | |
Interest Income and Expense and Net | -288.0M 0.00% | -288.0M +3.97% | -277.0M -217.87% | 235.0M +47.80% | |
Total Nonoperating Income and Expense | 87.0M -85.25% | 590.0M +426.79% | 112.0M -11.81% | 127.0M -31.72% | |
Income before Taxes | 897.0M +228.51% | -698.0M +50.76% | -463.0M -71.15% | -1.6B -148.30% | |
Income Taxes | 282.0M -70.72% | 963.0M +1,419.18% | -73.0M -35.40% | -113.0M +9.71% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 897.0M +228.51% | -698.0M +50.76% | -463.0M -71.15% | -1.6B -148.30% | |
Net Income from Continuing Operations Applicable to Common | 897.0M +228.51% | -698.0M +50.76% | -463.0M -71.15% | -1.6B -148.30% | |
Basic EPS and Net Income | 0.94 +225.33% | -0.75 +47.06% | -0.51 -71.98% | -1.82 -149.59% | |
Diluted EPS and Net Income | 0.93 +224.00% | -0.75 +47.06% | -0.51 -72.28% | -1.84 -374.63% | |
Basic Weighted Average Shares | 948.2M +1.59% | 933.4M +1.74% | 917.4M +4.06% | 881.6M -2.51% | |
Diluted Weighted Average Shares | 948.2M +1.59% | 933.4M +1.74% | 917.4M +4.06% | 881.6M -2.51% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 2.8B +16.37% | 2.4B +28.46% | 1.9B +59.47% | 1.2B -49.11% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 2.8B +16.37% | 2.4B +28.46% | 1.9B +59.47% | 1.2B -49.11% | |
Total Current Assets | 9.9B -0.90% | 10.0B +0.82% | 9.9B -3.11% | 10.3B -0.85% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | 2.5B -5.88% | 2.6B -2.26% | |
Total Long-Term Assets | 17.0B -10.25% | 19.0B -2.63% | 19.5B -4.71% | 20.4B -0.89% | |
Total Assets | 26.9B -7.01% | 29.0B -1.46% | 29.4B -4.18% | 30.7B -0.88% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 52.0M -43.48% | 92.0M N/A | N/A N/A | 500.0M 0.00% | |
Total Current Liabilities | 7.5B -7.82% | 8.1B -1.70% | 8.3B +4.45% | 7.9B +6.50% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 8.4B -3.88% | 8.8B -2.99% | 9.1B -4.36% | 9.5B +4.80% | |
Total Liabilities | 16.0B -5.78% | 16.9B +80,733.33% | -21.0M 0.00% | -21.0M -95.98% | |
Retained Earnings | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Stockholders Equity | 11.0B -8.74% | 12.0B -0.15% | 12.1B -9.20% | 13.3B -8.23% | |
Total Shares Outstanding | 951.3M +2.84% | 925.0M +2.05% | 906.4M N/A | N/A N/A | |
Cash Flow | |||||
Cash from Operating Activities | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Financials Ratio | |||||
Gross Margin | 45.18% +4.75% | 43.13% +5.22% | 40.99% +1.58% | 40.35% -3.41% | |
Operating Margin | 7.98% +172.00% | 2.94% +563.82% | -0.63% -92.62% | -8.58% -366.08% | |
Return on Assets | 3.21% +234.17% | -2.39% +55.18% | -1.54% -70.41% | -5.21% -145.97% | |
Return on Equity | 7.79% +234.48% | -5.79% +58.51% | -3.65% -68.41% | -11.56% -145.89% | |
Revenue Growth | -1.04% +27.39% | -0.81% -142.46% | 1.92% -50.95% | 3.91% +132.12% | |
Current Ratio | 1.32 +7.51% | 1.23 +2.57% | 1.20 -7.23% | 1.29 -6.90% | |
Cash Ratio | 0.37 +26.26% | 0.29 +30.69% | 0.23 +52.67% | 0.15 -52.22% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow